Centrica PLC Transaction in Own Shares
27 January 2025 - 6:00PM
RNS Regulatory News
RNS Number : 6904U
Centrica PLC
27 January 2025
|
Transactions in own
shares
Centrica plc
27 January
2025
Centrica
plc announces that it purchased on 24 January 2025 (through Goldman
Sachs International) 1,065,000 Centrica plc ordinary shares of 6
14/81 pence each at a price of 135.2100 pence
per share. The purchased shares will be held as treasury shares.
Such purchase was effected pursuant to the Company's buyback
programme announced on 8 August 2024 and in accordance with the
non-discretionary share repurchase agreement entered into with
Goldman Sachs International and pursuant to the Company's buyback
programme update announced on 27 December 2024 and in accordance
with the separate non-discretionary agreement with Goldman Sachs
International.
Since 8
August 2024, Centrica has purchased 154,000,164 ordinary shares at
a cost (excluding dealing and associated costs) of
£191,063,410.69.
Following the above purchase, Centrica plc holds 497,602,937
ordinary shares in treasury, and has 5,070,504,277 ordinary shares
in issue (excluding treasury shares).
In
accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the
Market Abuse Regulation) (as in force in the UK and as amended by
the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed
information about the individual purchases made by Goldman Sachs
International is set out below.
Transaction details: Centrica plc ordinary shares of 6
14/81 pence each
|
|
|
|
|
|
|
|
|
|
Goldman Sachs
International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of ordinary shares
purchased:
|
|
|
|
|
|
|
|
Volume weighted average price paid
per share:
|
|
|
|
|
Disaggregated information
The table attached contains detailed
information of the individual trades made by Goldman Sachs
International, as part of the buyback programme.
Click on, or paste the following link
into your web browser, to view the associated PDF
document.
http://www.rns-pdf.londonstockexchange.com/rns/6904U_1-2025-1-24.pdf
END
Enquiries:
Investors and Analysts
T: 01753 494900
E: ir@centrica.com
Centrica
plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor,
Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal
Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN
number: GB00B033F229
|
|
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
POSGZGZMRDVGKZM
Centrica (LSE:CNA)
Historical Stock Chart
From Jan 2025 to Feb 2025
Centrica (LSE:CNA)
Historical Stock Chart
From Feb 2024 to Feb 2025
